Table 2.

Utilization of Medications after PCI

	No improvement	Improvement
	(n = 18)	(n = 24)	P value
Aspirin	18 (100%)	23 (96%)	0.88
Clopidogrel	17 (94%)	22 (92%)	0.79
Nitrates	1 (6%)	-	0.88
PRN NTG	12 (67%)	11 (46%)	0.30
Coumadin	3 (17%)	5 (21%)	0.95
Beta-blocker	16 (89%)	24 (100%)	0.34
ACE inhibitor or ARB	16 (89%)	19 (80%)	0.67
Statins	17 (94%)	21 (88%)	0.81
Number of patients requiring changes in drug dosage at follow up
Beta-blocker	5 (28%)	9 (47%)	0.74
ACE inhibitor or ARB	5 (28%)	8 (33%)	0.96
Statins	3 (17%)	6 (25%)	0.78